BR9604818A - Composições de combinação contendo benazepril ou benazeprilat e valsartan - Google Patents

Composições de combinação contendo benazepril ou benazeprilat e valsartan

Info

Publication number
BR9604818A
BR9604818A BR9604818A BR9604818A BR9604818A BR 9604818 A BR9604818 A BR 9604818A BR 9604818 A BR9604818 A BR 9604818A BR 9604818 A BR9604818 A BR 9604818A BR 9604818 A BR9604818 A BR 9604818A
Authority
BR
Brazil
Prior art keywords
benazeprilat
valsartan
compositions containing
combination compositions
containing benazepril
Prior art date
Application number
BR9604818A
Other languages
English (en)
Portuguese (pt)
Inventor
David Saul Cohen
Gasparo Marc De
Randy Lee Webb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9604818A publication Critical patent/BR9604818A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9604818A 1995-04-07 1996-04-02 Composições de combinação contendo benazepril ou benazeprilat e valsartan BR9604818A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (1)

Publication Number Publication Date
BR9604818A true BR9604818A (pt) 1998-06-09

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9604818A BR9604818A (pt) 1995-04-07 1996-04-02 Composições de combinação contendo benazepril ou benazeprilat e valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (tr)
JP (1) JPH11503139A (tr)
KR (1) KR19980703647A (tr)
CN (1) CN1181019A (tr)
AU (1) AU5399096A (tr)
BR (1) BR9604818A (tr)
CA (1) CA2214143A1 (tr)
CZ (1) CZ313897A3 (tr)
HU (1) HUP9801593A2 (tr)
MX (1) MX9707683A (tr)
NO (1) NO974400D0 (tr)
PL (1) PL322529A1 (tr)
SK (1) SK133897A3 (tr)
TR (1) TR199701121T1 (tr)
WO (1) WO1996031234A1 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508894A (ja) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
AR032152A1 (es) * 2000-04-12 2003-10-29 Novartis Ag Uso de una combinacion de compuestos terapeuticos organicos para la fabricacion de un medicamento, un agente terapeutico, y una composicion farmaceutica
CA2415962C (en) * 2000-07-19 2010-07-06 Novartis Ag Valsartan salts
EP1671632A1 (en) * 2000-08-22 2006-06-21 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
WO2002049645A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
WO2004019876A2 (en) * 2002-08-28 2004-03-11 Curis, Inc. Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
JP5612674B2 (ja) 2009-05-20 2014-10-22 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミットベシュレンクテル ハフツング テルミサルタンを含む経口懸濁液
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
MX2016010011A (es) * 2014-01-31 2016-10-07 Janssen Pharmaceutica Nv Metodos para tratar y prevenir trastornos renales y trastornos del higado graso.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE148632T1 (de) * 1990-05-11 1997-02-15 Pfizer Synergistische therapeutische zusammensetzungen und verfahren
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
AU5399096A (en) 1996-10-23
MX9707683A (es) 1997-12-31
EP0820302A1 (en) 1998-01-28
CZ313897A3 (cs) 1998-01-14
NO974400L (no) 1997-09-23
PL322529A1 (en) 1998-02-02
WO1996031234A1 (en) 1996-10-10
CA2214143A1 (en) 1996-10-10
JPH11503139A (ja) 1999-03-23
HUP9801593A2 (hu) 1999-01-28
CN1181019A (zh) 1998-05-06
KR19980703647A (ko) 1998-12-05
TR199701121T1 (tr) 1998-03-21
NO974400D0 (no) 1997-09-23
SK133897A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
DE69637691D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69638056D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
ATE272067T1 (de) Aminoalkyl-glucosamin-phosphat-verbindungen und ihrer verwendung als adjuvanten und immunoeffektoren
DE69506095T2 (de) Diätfasern enthaltende Nahrungszusammensetzung
BR9505368A (pt) Composição cosmética ou dermatogógico água-em-óleo
FI973475A (fi) Koostumus ja sitä sisältävä tuote
BR9609831A (pt) Composições cosméticas e/ou farmacêuticas antipruríticas
DE69513307T2 (de) Zusammensetzung und verwendung
BR9604818A (pt) Composições de combinação contendo benazepril ou benazeprilat e valsartan
BR9606809A (pt) Composição inseticidamente ativa
PT728814E (pt) Composicao betuminosa
DE69633937D1 (de) Polyamid- oder polyesterzusammensetzung
HUP9802997A3 (en) Antisudorific and/or deodorant compositions
BR9609903A (pt) ComposiçÃo inseticidamente ativa
DE69616374D1 (de) Germizide zusammensetzung
DE69605016T2 (de) Intumeszenzzusammensetzung
GB9724859D0 (en) Compounds and their use as antibacterial agents
FR2739382B1 (fr) Fraction ribosomale et composition la contenant
BR9610382A (pt) Composição de tratamento do cableo
BR9607946A (pt) Composição
DE59505197D1 (de) Sicherheitskombination
ATE183114T1 (de) Feste zusammensetzung
FR2747308B1 (fr) Association de margousier, de (-) hydroxycitrate et de ceramides et compositions les renfermant
BR9610206A (pt) Espiroxazinas fotocrônicas composições e artigos contendo as mesmas

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law